210 related articles for article (PubMed ID: 35490364)
21. A comparative study of CSF neurofilament light and heavy chain protein in MS.
Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
[TBL] [Abstract][Full Text] [Related]
22. Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension.
Engel S; Halcour J; Ellwardt E; Uphaus T; Steffen F; Zipp F; Bittner S; Luessi F
Fluids Barriers CNS; 2023 Jan; 20(1):3. PubMed ID: 36631830
[TBL] [Abstract][Full Text] [Related]
23. Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosis.
Yalachkov Y; Anschütz V; Jakob J; Schaller-Paule MA; Schäfer JH; Reiländer A; Friedauer L; Behrens M; Steffen F; Bittner S; Foerch C
Mult Scler Relat Disord; 2022 Jul; 63():103822. PubMed ID: 35504173
[TBL] [Abstract][Full Text] [Related]
24. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
25. Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes.
Wong YYM; Bruijstens AL; Barro C; Michalak Z; Melief MJ; Wierenga AF; van Pelt ED; Neuteboom RF; Kuhle J; Hintzen RQ
Neurology; 2019 Sep; 93(10):e968-e974. PubMed ID: 31383792
[TBL] [Abstract][Full Text] [Related]
26. Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Shi J; Qin X; Chang X; Wang H; Guo J; Zhang W
J Cell Mol Med; 2022 Jan; 26(2):583-587. PubMed ID: 34866307
[TBL] [Abstract][Full Text] [Related]
27. High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS.
Thebault S; R Tessier D; Lee H; Bowman M; Bar-Or A; Arnold DL; L Atkins H; Tabard-Cossa V; Freedman MS
Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e598. PubMed ID: 31516913
[TBL] [Abstract][Full Text] [Related]
28. Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.
Piehl F; Kockum I; Khademi M; Blennow K; Lycke J; Zetterberg H; Olsson T
Mult Scler; 2018 Jul; 24(8):1046-1054. PubMed ID: 28627962
[TBL] [Abstract][Full Text] [Related]
29. The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis.
Adams A; Tilden W; Bestwick J; Holden D; Bianchi L; Smets I; Giovannoni G; Gnanapavan S
Eur J Neurol; 2022 Sep; 29(9):2754-2760. PubMed ID: 35615966
[TBL] [Abstract][Full Text] [Related]
30. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
[TBL] [Abstract][Full Text] [Related]
31. Serum neurofilament light chain is more strongly associated with T2 lesion volume than with number of T2 lesions in patients with multiple sclerosis.
Wenger KJ; Hoelter MC; Yalachkov Y; Hendrik Schäfer J; Özkan D; Steffen F; Bittner S; Hattingen E; Foerch C; Schaller-Paule MA
Eur J Radiol; 2023 Sep; 166():111019. PubMed ID: 37549559
[TBL] [Abstract][Full Text] [Related]
32. Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus.
Margraf NG; Dargvainiene J; Theel E; Leypoldt F; Lieb W; Franke A; Berger K; Kuhle J; Kuhlenbaeumer G
J Neurol; 2023 Apr; 270(4):2128-2138. PubMed ID: 36624182
[TBL] [Abstract][Full Text] [Related]
33. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
Novakova L; Zetterberg H; Sundström P; Axelsson M; Khademi M; Gunnarsson M; Malmeström C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
Neurology; 2017 Nov; 89(22):2230-2237. PubMed ID: 29079686
[TBL] [Abstract][Full Text] [Related]
34. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J
Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
Gaetani L; Salvadori N; Lisetti V; Eusebi P; Mancini A; Gentili L; Borrelli A; Portaccio E; Sarchielli P; Blennow K; Zetterberg H; Parnetti L; Calabresi P; Di Filippo M
J Neurol; 2019 Sep; 266(9):2157-2163. PubMed ID: 31129709
[TBL] [Abstract][Full Text] [Related]
36. Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients.
Vecchio D; Puricelli C; Malucchi S; Virgilio E; Martire S; Perga S; Passarelli F; Valentino P; Di Sapio A; Cantello R; Dianzani U; Comi C
Mult Scler Relat Disord; 2024 Feb; 82():105412. PubMed ID: 38198989
[TBL] [Abstract][Full Text] [Related]
37. Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.
Alagaratnam J; De Francesco D; Zetterberg H; Heslegrave A; Toombs J; Kootstra NA; Underwood J; Gisslen M; Reiss P; Fidler S; Sabin CA; Winston A
J Neurovirol; 2022 Feb; 28(1):54-63. PubMed ID: 34874540
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis.
Robinson T; Abdelhak A; Bose T; Meinl E; Otto M; Zettl UK; Dersch R; Tumani H; Rauer S; Huss A
Cells; 2020 Nov; 9(12):. PubMed ID: 33255854
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis.
Rajda C; Galla Z; Polyák H; Maróti Z; Babarczy K; Pukoli D; Vécsei L
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290514
[TBL] [Abstract][Full Text] [Related]
40. Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
Uher T; McComb M; Galkin S; Srpova B; Oechtering J; Barro C; Tyblova M; Bergsland N; Krasensky J; Dwyer M; Havrdova EK; Posova H; Vaneckova M; Zivadinov R; Horakova D; Kuhle J; Ramanathan M
Mult Scler; 2021 Feb; 27(2):220-231. PubMed ID: 32255388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
